PR

Prestige Biologics Co., Ltd.

A biopharmaceutical CDEMO specializing in antibody-based therapeutics.

334970 | KO

Overview

Corporate Details

ISIN(s):
KR7334970001
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명1로 197, 청주시

Description

Prestige Biologics is a biopharmaceutical Contract Development and Engineering Manufacturing Organization (CDEMO) that provides end-to-end solutions for the entire lifecycle of a drug, from initial development to commercial production. The company specializes in antibody-based therapeutics and offers a comprehensive suite of services including process development, analytical testing, manufacturing of drug substances and drug products, and secondary packaging for clinical trials. It supports clients through all clinical stages by providing services optimized for their specific needs, utilizing advanced equipment and GMP-compliant facilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 65.5 KB
2025-09-19 00:00
사업보고서 (2025.06)
Korean 493.5 KB
2025-09-18 00:00
감사보고서제출
Korean 18.5 KB
2025-09-15 00:00
[기재정정]주주총회소집공고
Korean 176.8 KB
2025-09-12 00:00
[기재정정]주주총회소집결의
Korean 25.6 KB
2025-09-11 00:00
주주총회소집공고
Korean 148.4 KB
2025-09-11 00:00
주주총회소집결의
Korean 20.3 KB
2025-08-13 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-07-31 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 13.4 KB
2025-06-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-06-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-26 00:00
투자판단관련주요경영사항 (바이오의약품 위탁생산 계약 진행의 건)
Korean 8.3 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-28 00:00
임시주주총회결과
Korean 6.5 KB
2025-03-28 00:00
대표이사변경
Korean 9.0 KB

Automate Your Workflow. Get a real-time feed of all Prestige Biologics Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Prestige Biologics Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Prestige Biologics Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.